血管紧张素转换酶抑制剂 (ＡＣＥＩ)作为降低血浆中血管紧张素Ⅱ浓度 ,降低周围血管阻力 ,治疗高血压 ,减轻心脏前后负荷及有效控制肾性高血压 ,已被临床广泛使用。ＡＣＥＩ制剂的不断发展 ,又为临床更加合理地、有选择地应用不同类型ＡＣＥＩ提供了保障。但此类药物引进咳嗽的 Angiotensin converting enzyme inhibitor (ACEI) has been widely used clinically as a means to reduce plasma angiotensin II concentration, reduce peripheral vascular resistance, treat hypertension, reduce cardiac anteroposterior load and effectively control renal hypertension. ACEI preparations continue to develop, but also for the clinical more rational and selective application of different types of ACEI provides a guarantee. But such drugs introduce cough